Estrogen-dependent inherited angioedema.
暂无分享,去创建一个
[1] M. Whitehead,et al. Effects of oestrogen‐only and oestrogen–progestogen replacement therapy upon circulating angiotensin I‐converting enzyme activity in postmenopausal women , 2003, Clinical endocrinology.
[2] M. Kurabayashi,et al. Effects of hormone replacement therapy on serum angiotensin-converting enzyme activity and plasma bradykinin in postmenopausal women according to angiotensin-converting enzyme-genotype. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.
[3] A. Toutain,et al. Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission. , 2001, The Journal of allergy and clinical immunology.
[4] K. Binkley,et al. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. , 2000, The Journal of allergy and clinical immunology.
[5] K. Bork,et al. Hereditary angioedema with normal C1-inhibitor activity in women , 2000, The Lancet.
[6] A. Davis. C1 Inhibitor Gene and Hereditary Angioedema , 1998 .
[7] J. Volanakis. The human complement system in health and disease , 1998 .
[8] J. Chao,et al. Regulation of bradykinin B2‐receptor expression by oestrogen , 1997, British journal of pharmacology.
[9] F. Rosen,et al. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. , 1996, The New England journal of medicine.
[10] A. Sacchi,et al. Molecular basis of estrogen regulation of Hageman factor XII gene expression. , 1995, Endocrinology.
[11] N. Hoem,et al. Contact factors in plasma from women on oral contraception--significance of factor XI for the measured activity of factor XII. , 1994, Thrombosis research.
[12] S. Tarlo,et al. C1 esterase inhibitor in pregnancy. , 1992, The Journal of allergy and clinical immunology.
[13] S. Leodolter,et al. C1-Esterase Inhibitor in Uncomplicated Pregnancy and Mild and Moderate Preeclampsia , 1991, Thrombosis and Haemostasis.
[14] A. Falus,et al. Hormonal regulation of complement biosynthesis in human cell lines--I. Androgens and gamma-interferon stimulate the biosynthesis and gene expression of C1 inhibitor in human cell lines U937 and HepG2. , 1990, Molecular immunology.
[15] K. Whaley,et al. Monocyte C1‐inhibitor synthesis in patients with C1‐inhibitor deficiency , 1989, European journal of clinical investigation.
[16] F. Rosen,et al. Angioedema induced by a peptide derived from complement component C2 , 1988, The Journal of experimental medicine.
[17] S. Williams,et al. Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII. , 1988, The Journal of laboratory and clinical medicine.
[18] J. Jespersen,et al. Increased Euglobulin Fibrinolytic Potential in Women on Oral Contraceptives Low in Oestrogen – Levels of Extrinsic and Intrinsic Plasminogen Activators, Prekallikrein, Factor XII, and C1-Inactivator , 1985, Thrombosis and Haemostasis.
[19] Robert B Sim,et al. The effect of danazol on the production of C1 inhibitor in the guinea pig. , 1984, Complement.
[20] R. Colman,et al. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. , 1983, The New England journal of medicine.
[21] D. Ogston,et al. C1 inactivator level in pregnancy. , 1981, Thrombosis research.
[22] O. Ratnoff,et al. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives. , 1980, The Journal of laboratory and clinical medicine.
[23] M. Cicardi,et al. Treatment of acute attacks of hereditary angioedema with C1-inhibitor concentrate. , 1980, Annals of allergy.
[24] J. Gelfand,et al. Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. , 1980, The New England journal of medicine.
[25] D. Alling,et al. Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.
[26] J. Atkinson,et al. Hereditary angioedema: the clinical syndrome and its management. , 1976, Annals of internal medicine.
[27] A. Sheffer,et al. Tranexamic acid therapy in hereditary angioneurotic edema. , 1972, The New England journal of medicine.
[28] F. Rosen,et al. Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema. , 1971, The Journal of clinical investigation.
[29] F. Rosen,et al. Hereditary angioneurotic edema: a clinical survey. , 1966, Pediatrics.
[30] R. R. Evans,et al. A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. , 1963, The American journal of medicine.
[31] W. Spaulding. METHYLTESTOSTERONE THERAPY FOR HEREDITARY EPISODIC EDEMA (HEREDITARY ANGIONEUROTIC EDEMA) , 1960 .